SEC Form 4 · accession 0001225208-15-001415
Merck & Co., Inc. · MRK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Adam H Schechter
Officer — EVP & Pres-Global Human Health
Period of report
Jan 15, 2015
Accepted (ET)
Jan 15, 2015 · 3:55 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000310158
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jan 15, 2015 | M | 50,000 | $44.19 | A | 50,000 | D | |
| Common Stock | Jan 15, 2015 | M | 19,200 | $35.09 | A | 69,200 | D | |
| Common Stock | Jan 15, 2015 | M | 5,000 | $34.47 | A | 74,200 | D | |
| Common StockF2 | Jan 15, 2015 | S | 74,200 | $62.4828 | D | 0 | D | |
| Common StockF3 | holding | — | — | — | 70,795 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $34.47 | Jan 15, 2015 | M | 5,000 | D | Feb 1, 2007 | Jan 31, 2016 | Common Stock | 5,000 | 0 | D |
| Stock Option (right to buy)F5 | $44.19 | Jan 15, 2015 | M | 50,000 | D | Mar 2, 2008 | Mar 1, 2017 | Common Stock | 50,000 | 0 | D |
| Stock Option (right to buy)F6 | $35.09 | Jan 15, 2015 | M | 19,200 | D | Mar 3, 2007 | Mar 2, 2016 | Common Stock | 19,200 | 0 | D |
Explanation of responses
- F1The exercise and sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.1200 to $62.9800, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- F3Holdings include shares acquired in dividend reinvestment transactions.
- F4The option became exercisable in equal installments on 2/1/2007, 2/1/2008 and 2/1/2009.
- F5The option became exercisable in equal installments on 3/2/2008, 3/2/2009 and 3/2/2010.
- F6The option became exercisable in equal installments on 3/3/2007, 3/3/2008 and 3/3/2009.